Intermountain Inpatient Bilirubin Decision Accuracy Study Using Smartphone-based Measurements by Picterus Jaundice Pro

Status unconfirmed

Conditions studied: Neonatal Jaundice

In brief

The goal of this project is to evaluate the performance of Picterus Jaundice Pro in an American population, including preterm and term newborns and pre- and post- phototherapy.

Key facts

Study ID

NCT06329843

Run by

Picterus AS

People needed

500

Starts

2024-02-12

Expected to finish

2024-05-01

Last updated by the study team

2024-03-26

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• the patient is free of skin rash, bruising, or other medical conditions that can interfere with transcutaneous measurement
• (preterm) < = 35 weeks gestational age
• (term) > 35 weeks gestational age
• the patient has not been excluded by PI discretion.

You may not qualify if…

• Neonates will be excluded from participation if all four inclusion criteria listed above are not met.

Where it is running

• Intermountain Health — Salt Lake City, Utah, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.